Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer
- 1 April 2017
- journal article
- Published by Elsevier in Nitric Oxide
- Vol. 64, 22-30
Abstract
No abstract availableKeywords
Funding Information
- nstituto de Oncología “Ángel H. Roffo” - Universidad de Buenos Aires
- Escuela Técnica ORT and Centro Médico VIDT SRL
This publication has 22 references indexed in Scilit:
- NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001Redox Biology, 2015
- Intravesical therapy for bladder cancerExpert Opinion on Pharmacotherapy, 2015
- iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biologyUrologic Oncology: Seminars and Original Investigations, 2014
- Trimodality treatment in the conservative management of infiltrating bladder cancer: A critical review of the literatureCritical Reviews in Oncology/Hematology, 2013
- The Abscopal Effect Associated With a Systemic Anti-melanoma Immune ResponseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPsClinical Cancer Research, 2012
- How Can We Overcome Tumor Hypoxia in Radiation Therapy?Journal of Radiation Research, 2011
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder CarcinomaJournal of Clinical Oncology, 2010
- Bladder cancerThe Lancet, 2009
- Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patientsNitric Oxide, 2005